Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    First-in-class vs. Best-in-class: What Biotech Investors Need To Know

    Ross McNaughton and Moira Sy examine the strategic calculus behind biotech investment decisions, analyzing whether venture capital and M&A activity gravitates toward pioneering first-in-class assets or optimized best-in-class therapies. The analysis explores how advances in AI, regulatory pathways, and market dynamics are reshaping risk profiles and determining which innovation strategies attract capital in today's selective funding environment.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Winston Taylor
    Winston Taylor
  • Article

    The Building Safety Levy Countdown With Last Minute Changes

    England's building safety levy takes effect October 1, 2026, introducing new per-square-meter charges on residential developments. Recent amendment regulations have refined exemptions and discount eligibility, while the absence of transitional provisions creates urgency for developers to finalize building control applications before the implementation date.
United Kingdom
Real Estate and Construction
Winston Taylor
Winston Taylor
  • Article

    EU Cyber Resilience Act Incident Reporting Requirements Now Apply To Manufacturers Of Connected Products

    The EU Cyber Resilience Act's incident reporting requirements are now in effect for manufacturers of connected products, with the ENISA single reporting platform operational since September 2026. Manufacturers must navigate complex notification timelines ranging from 24 hours to one month depending on incident severity, with potential fines reaching EUR15M or 2.5% of global turnover for non-compliance starting December 2027. Understanding these cascading reporting obligations to CSIRTs, ENISA, and affected
    European UnionCorporate/Commercial Law
    Winston Taylor
    Winston Taylor
  • Article

    ESOS Phase 4. Does your business qualify? And what’s changed since Phase 3?

    The U.K.'s Energy Savings Opportunity Scheme (ESOS) Phase 4 brings mandatory energy assessment requirements for large businesses, with critical compliance deadlines approaching in 2026 and 2027. Understanding qualification criteria, new reporting obligations, and enforcement consequences is essential for organizations that may fall within scope, including those affected by recent structural changes or M&A activity.
    United KingdomCorporate/Commercial Law
    Winston Taylor
    Winston Taylor
  • Showing 1–4 of 4 results

    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics